http://rdf.ncbi.nlm.nih.gov/pubchem/reference/32914745

Outgoing Links

Predicate Object
contentType Journal Article|Randomized Controlled Trial|Research Support, N.I.H., Extramural|Research Support, Non-U.S. Gov't
endingPage 665
issn 0361-8609
1096-8652
issueIdentifier 10
pageRange 661-665
publicationName American Journal of Hematology
startingPage 661
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_77e2488754b2b37f99f84e3d30d28ece
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_72a1214c9657a4139edf3e3780c46954
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_92bb78d28d74a1f1cc2462c45acc0d55
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_28a22991cd4024aff770579cab8dadd8
bibliographicCitation Hasan A, Michel M, Patel V, Stasi R, Cunningham-Rundles S, Leonard JP, Bussel J. Repeated courses of rituximab in chronic ITP: Three different regimens. Am J Hematol. 2009 Oct;84(10):661–5. PMID: 19731307; PMCID: PMC2783818.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c08b523f55aae239fa872b8fe8768392
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_86fd5e93b0ab04aac056e8da2de5432c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a03d059bef792cbc8e431fe9a9b7ce64
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_191f9f901622232de240d4cd0276f4df
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c41267dcc59a0b71184ff72e3239df50
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6a8c69f9a7aca9635e119cb6c7666afa
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dc55a2ea604b1d16c9c9aa6ff7efe69f
date 2009-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/PMC2783818
https://doi.org/10.1002/ajh.21512
https://pubmed.ncbi.nlm.nih.gov/19731307
isPartOf https://portal.issn.org/resource/ISSN/1096-8652
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/422
https://portal.issn.org/resource/ISSN/0361-8609
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Repeated courses of rituximab in chronic ITP: Three different regimens
discusses http://id.nlm.nih.gov/mesh/M0244307
http://id.nlm.nih.gov/mesh/M0001357
http://id.nlm.nih.gov/mesh/M0544940
http://id.nlm.nih.gov/mesh/M0011157
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D000911Q000627
http://id.nlm.nih.gov/mesh/D000911Q000008
http://id.nlm.nih.gov/mesh/D007155Q000008
http://id.nlm.nih.gov/mesh/D007155Q000627
http://id.nlm.nih.gov/mesh/D016553Q000188
hasSubjectTerm http://id.nlm.nih.gov/mesh/D004334
http://id.nlm.nih.gov/mesh/D058846
http://id.nlm.nih.gov/mesh/D000911Q000009
http://id.nlm.nih.gov/mesh/D002908
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D012189
http://id.nlm.nih.gov/mesh/D010865
http://id.nlm.nih.gov/mesh/D016896
http://id.nlm.nih.gov/mesh/D004359
http://id.nlm.nih.gov/mesh/D004305
http://id.nlm.nih.gov/mesh/D011446
http://id.nlm.nih.gov/mesh/D007155Q000009
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D000069283
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9887
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5978
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164145
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45358158
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_04330147d2af6e87dc0a91a4a90fdaf8
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134755071
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3717450
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71296921
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5388993
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6324671
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5865
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2907
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129717275

Total number of triples: 69.